JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258325

Human BCL2L2 knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

Human BCL2L2 knockout HeLa cell lysate suitable for Sanger seq, WB. View our extensive range of validated lysates from normal and diseased human, mouse and rat tissue.

View Alternative Names

Apoptosis regulator Bcl-W, B2CL2_HUMAN, BCL 2 Like 2, BCL W, Bcl 2 like 2 protein, Bcl-2-like protein 2, Bcl2-L-2, KIAA0271, PPP1R51, Protein phosphatase 1 regulatory subunit 51

4 Images
Western blot - Human BCL2L2 knockout HeLa cell lysate (AB258325)
  • WB

Lab

Western blot - Human BCL2L2 knockout HeLa cell lysate (AB258325)

False colour image of Western blot : Anti-BCL2L2 antibody staining at 1/500 dilution, shown in green; loading control ab7291 (Mouse anti-Alpha Tubulin [DM1A]) staining at 1/20000 dilution, shown in red. In Western blot, the antibody was shown to bind specifically to BCL2L2. A band was observed at 17 kDa in wild-type HeLa cell lysates with no signal observed at this size in BCL2L2 knockout cell line ab265368 (knockout cell lysate ab258325). To generate this image, wild-type and BCL2L2 knockout HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Anti-BCL2L2 antibody at 1/500 dilution

Lane 1:

Wild-type HeLa cell lysate at 40 µg

Lane 2:

Western blot - Human BCL2L2 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-bcl2l2-knockout-hela-cell-line-ab265368'>ab265368</a>)

Lane 2:

Western blot - Human BCL2L2 knockout HeLa cell lysate (ab258325)

Lane 2:

BCL2L2 knockout HeLa cell lysate at 40 µg

Lane 3:

HepG2 cell lysate

Lane 4:

MOLT-4 cell lysate at 40 µg

Secondary

Lanes 1 - 4:

Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/20000 dilution

Lanes 1 - 4:

Western blot - Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-irdye-680rd-preadsorbed-ab216776'>ab216776</a>) at 1/20000 dilution

Observed band size: 17 kDa

false

Western blot - Human BCL2L2 knockout HeLa cell lysate (AB258325)
  • WB

Lab

Western blot - Human BCL2L2 knockout HeLa cell lysate (AB258325)

Lane 1 : Wild-type HeLa cell lysate 40 μg
Lane 2 : BCL2L2 knockout HeLa cell lysate 40 μg
Lane 3 : HepG2 cell lysate 40 μg
Lane 4 : MOLT-4 cell lysate 40 μg
False colour image of Western blot : Anti-BCL2L2 antibody staining at 1/500 dilution, shown in green; loading control ab7291 (Mouse anti-Alpha Tubulin [DM1A]) staining at 1/20000 dilution, shown in red. In Western blot, the antibody was shown to bind specifically to BCL2L2. A band was observed at 17 kDa in wild-type HeLa cell lysates with no signal observed at this size in BCL2L2 knockout cell line ab265368 (knockout cell lysate ab258325). To generate this image, wild-type and BCL2L2 knockout HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

anti-BCL2L2 antibody at 1/500 dilution

Lane 1:

Wild-type HeLa cell lysate at 40 µg

Lane 2:

BCL2L2 knockout HeLa cell lysate at 40 µg

Lane 2:

Western blot - Human BCL2L2 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-bcl2l2-knockout-hela-cell-line-ab265368'>ab265368</a>)

Lane 3:

HepG2 cell lysate at 40 µg

Lane 4:

MOLT-4 cell lysate at 40 µg

false

Sanger Sequencing - Human BCL2L2 knockout HeLa cell lysate (AB258325)
  • Sanger seq

Unknown

Sanger Sequencing - Human BCL2L2 knockout HeLa cell lysate (AB258325)

Allele-1 : 1 bp insertion in exon3

Sanger Sequencing - Human BCL2L2 knockout HeLa cell lysate (AB258325)
  • Sanger seq

Unknown

Sanger Sequencing - Human BCL2L2 knockout HeLa cell lysate (AB258325)

Allele-2 : Insertion of the selection cassette in exon3

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing,Western blot

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon3 and Insertion of the selection cassette in exon3.

Disease

Adenocarcinoma

style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Sanger seq": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }
style
left-column
style
left-column

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

style
left-column

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258325-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human BCL2L2 knockout HeLa cell lysate", "number":"AB258325-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB258325-CMP02", "productcode":"" } ] } } }
style
left-column

Properties and storage information

Gene name
BCL2L2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing, Western blot
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Bcl2L2 also known as Bcl-w is a protein that functions as an anti-apoptotic member of the Bcl-2 family. It has a molecular weight of approximately 21 kDa. This protein is expressed in various tissues such as the brain testis and kidney suggesting it plays a significant role in these organs. Bcl2L2's expression pattern and structure contribute to its function in regulating apoptotic pathways by inhibiting cell death signals.
Biological function summary

The function of Bcl-w involves its role in promoting cell survival. It is part of a complex network of interactions within the Bcl-2 family. This protein family includes both pro-apoptotic and anti-apoptotic proteins and Bcl-w helps maintain the balance by impeding apoptosis. The protein localizes to the mitochondrial outer membrane where it sequesters pro-apoptotic members such as Bax and Bak preventing the release of cytochrome c an essential step in the apoptosis process.

Pathways

The Bcl-w protein integrates into the intrinsic mitochondrial apoptosis pathway. It interacts closely with other Bcl-2 family proteins to ensure cellular homeostasis. Important pathways involving Bcl-w include the mitochondrial or intrinsic apoptosis pathway and the PI3K/AKT signaling pathway both of which regulate cell survival. Related proteins include Bcl-2 Bcl-XL Bax and Bak. These proteins collectively modulate the apoptosis signaling and therefore influence cell fate decisions within tissues where Bcl-w is expressed.

Bcl-w has been implicated in cancer and neurodegenerative diseases due to its role in cell survival and apoptosis regulation. In certain cancers the overexpression of Bcl-w protein can lead to unchecked cell proliferation by avoiding apoptosis therefore promoting tumor growth. In neurodegenerative diseases such as Alzheimer's disease altered expression of Bcl-w may contribute to neuronal survival affecting disease progression. Proteins like Bax and Bak which promote apoptosis are often in regulatory interplay with Bcl-w in these conditions highlighting the delicate balance of pro-survival and pro-apoptotic forces in disease states.
style
left-column

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

style
left-column

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

style
left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column
style
left-column

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
style
left-column
style
right-column
style
bg-slate-100

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com